Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension (PH)”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Testing effectiveness (Phase 2)Looking for participantsNCT07175038
What this trial is testing

ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease
AllRock Bio, Inc. 40
Large-scale testing (Phase 3)Ended earlyNCT03496623
What this trial is testing

Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
United Therapeutics 188
Testing effectiveness (Phase 2)Study completedNCT01728220
What this trial is testing

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Bellerophon Pulse Technologies 159
Not applicableNot Yet RecruitingNCT07263958
What this trial is testing

Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)

Who this might be right for
Pulmnary HypertensionCOPDPulmonary Hypertension Secondary to Lung Disease and/or Hypoxia
University of Sao Paulo General Hospital 15
Not applicableUnknownNCT01979822
What this trial is testing

LenusPro Safety (LPS) Study in Patients With PH

Who this might be right for
Pulmonary Hypertension
University Medicine Greifswald 30
Not applicableNot Yet RecruitingNCT07344207
What this trial is testing

GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)

Who this might be right for
Pulmonary Hypertension (Diagnosis)Pre-operative AssessmentPostoperative Complications (Cardiopulmonary)+1 more
Taipei Veterans General Hospital, Taiwan 1,380
Not applicableWithdrawnNCT05205265
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Testing effectiveness (Phase 2)Ended earlyNCT01065051
What this trial is testing

Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics

Who this might be right for
Hypertension, PulmonaryVentricular Dysfunction, Left
Bayer 1
Not applicableLooking for participantsNCT05968859
What this trial is testing

Pulmonary Hypertension Peripheral Limitations

Who this might be right for
Pulmonary Arterial HypertensionHealthy
Mayo Clinic 45
Not applicableStudy completedNCT00675051
What this trial is testing

Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
University of California, San Francisco 20
Not applicableUnknownNCT05935865
What this trial is testing

Monitoring of the Influence of Approved PH-therapies RV-PA Coupling

Who this might be right for
Pulmonary Hypertension
University of Giessen 100
Not applicableUnknownNCT06003244
What this trial is testing

High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

Who this might be right for
Pulmonary Vascular DiseasePulmonary Artery HypertensionChronic Thromboembolic Pulmonary Hypertension
University of Zurich 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT07285655
What this trial is testing

Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Who this might be right for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc. 344
Testing effectiveness (Phase 2)Looking for participantsNCT07221513
What this trial is testing

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
Salubris Biotherapeutics Inc 30
Large-scale testing (Phase 3)Ended earlyNCT03037580
What this trial is testing

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction

Who this might be right for
Pulmonary HypertensionHeart Failure With Preserved Ejection Fraction
United Therapeutics 84
Early research (Phase 1)Study completedNCT04370873
What this trial is testing

Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)

Who this might be right for
Pulmonary Hypertension
Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT03198910
What this trial is testing

Retrospective Data Analysis of Data From the Zurich PH Registry

Who this might be right for
Pulmonary HypertensionChronic Thromboembolic Pulmonary HypertensionPulmonary Artery Hypertension
University of Zurich 313
Not applicableStudy completedNCT03667794
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)

Who this might be right for
Pulmonary Hypertension
Universitätsmedizin Mannheim 75
Testing effectiveness (Phase 2)Looking for participantsNCT06635850
What this trial is testing

Mosliciguat in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseLung Diseases+3 more
Pulmovant, Inc. 120
Not applicableAvailableNCT05572996
What this trial is testing

Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseCombined Pulmonary Fibrosis and Emphysema
Ferrer Internacional S.A.
Load More Results